Imaging of Integrins as Biomarkers for Tumor Angiogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|28|2943-2973

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.28, 2008-10, pp. : 2943-2973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2661-2672

Bentham Science Publishers

Access to resources Recommend Favorite

A Concise Review of Current Radiopharmaceuticals in Tumor Angiogenesis Imaging

By  

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1032-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting integrins for the control of tumour angiogenesis

By Akalu Abebe   Cretu Alexandra   Brooks Peter C  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1475-1486

Informa Healthcare

Access to resources Recommend Favorite

Radiolabeled Tracers for Imaging of Tumor Angiogenesis and Evaluation of Anti-Angiogenic Therapies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 13, 2004-05 ,pp. : 1439-1455

Bentham Science Publishers

Access to resources Recommend Favorite

Contrast Agents and Applications to Assess Tumor Angiogenesis In Vivo by Magnetic Resonance Imaging

By  

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 77-91

Bentham Science Publishers

Access to resources Recommend Favorite